Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications.
The molecular changes in malignant epithelium in the head and neck offer possibilities for the development of diagnostic, prognostic and other markers. This article reviews recent developments in this field.
Scully
C
C
Eastman Dental Institute for Oral Health Care Sciences, University College London, University of London, 256 Gray's Inn Road, WC1X 8LD, London, UK. c.scully@eastman.ucl.ac.uk
Field
J K
JK
Tanzawa
H
H
D002294:Carcinoma, Squamous Cell / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D016158:Genes, p53 / Q000235:genetics; D005819:Genetic Markers; D015316:Genetic Therapy / Q000379:methods; D006258:Head and Neck Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D006801:Humans; D015336:Molecular Probe Techniques; D009062:Mouth Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D009367:Neoplasm Staging; D011379:Prognosis; D012307:Risk Factors
D005819:Genetic Markers